Hg-41 * outcomes for patients with recurrent malignant glioma enrolled on phase ii clinical trials: an analysis of contemporary children's oncology group (cog) and pediatric brain tumor consortium (pbtc) trials

Hg-41 * outcomes for patients with recurrent malignant glioma enrolled on phase ii clinical trials: an analysis of contemporary children's oncology group (cog) and pediatric brain tumor consortium (pbtc) trials:

(Source: Neuro-Oncology)
from glioma via o.lakala70 on Inoreader
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1XRC2XW
via IFTTT